SINGAPORE - Blood plasma from recovered Covid-19 patients is reserved for those who are not responding well to initial treatments for the coronavirus, the National Centre for Infectious Diseases (NCID) has said.
In convalescent plasma therapy, the blood plasma, which may contain antibodies against Covid-19, is given to infected patients to help them recover faster.
It is used to complement initial treatments of steroids and antivirals, and administered as part of a monitored programme from the NCID and Tan Tock Seng Hospital, in collaboration with the Health Sciences Authority and Duke-NUS, said Dr Shawn Vasoo, clinical director of NCID, in response to queries from The Straits Times last week.